What are the main things investors want to see when assessing the value of a project?

Based on your project documentation and your strategic communications regarding Force Vector 360, an investor assessing the worth of this project will look past standard hardware features to evaluate it as a scalable digital health platform and a category-creating technology.

Because you are introducing a completely new mechanical environment with no direct precedent, an investor's assessment will center on the following core pillars:

1. Proprietary Data Monopoly (The "Fifth Pillar" of Clinical Insight)

The single most valuable asset to a modern digital health investor is the data your system captures.

The Value: Investors want to see that your prototype generates a net-new physiological data class: objective, physics-defined functional-movement telemetry.

The Differentiation: You are positioning this data as the missing "fifth pillar" of clinical insight to sit alongside existing pillars like imaging, EHRs, vitals, and claims. Investors will recognize that while major players like Google and GE HealthCare have massive data lakes for imaging and diagnostics, they completely lack quantitative, high-resolution telemetry for real-time human movement and coordination. Your machine closes that loop.

2. Standardized, Clinician-Independent Rehab Dosing

Traditional physical therapy is highly variable, dependent entirely on the individual skill of the therapist and highly prone to "vector drift" when a patient experiences pain or fatigue.

The Value: Investors look for scalability. Because your gravity-neutral, 360° single-plane arc mechanically constrains the movement pathway, it ensures identical repetition quality.

The Commercial Appeal: It standardizes treatment dosing across multiple clinics or an entire hospital network, minimizing human error, accelerating recovery, and reducing long-term musculoskeletal (MSK) cost burdens.

3. A Total Addressable Market (TAM) Across the Lifecycle

Investors want to ensure that a product isn't restricted to a niche market. Your multi-segment mechanical approach allows you to claim a massive, diverse user base:

Geriatrics: Capturing the massive aging population by treating the root cause of fall risks (neuromuscular coordination and timing loss) rather than just raw strength.

Orthopedics & Sports Med: Serving athletes and gym patrons by acting as a high-fidelity movement teacher that exposes hidden physical "dead spots" and asymmetries.

Neurology: Providing a safe, closed-loop environment for stroke and traumatic brain injury (TBI) neuro-rehabilitation.

4. Clear Enterprise Validation Pathways (e.g., The VA Strategy)

An early-stage startup needs a clear "beachhead market" to prove its worth.

The Strategy: The Veterans Health Administration (VA) acts as a perfect investment proof-of-concept. Showing an investor that your system maps directly onto the VA's highest cost liabilities—chronic MSK disabilities and aging-in-place initiatives—demonstrates a sophisticated, high-value commercial pathway.

5. Transitioning from "Research-Grade" to Commercial Compliance

As noted in your earlier evaluations, a medical AI currently classifies the prototype as research-grade due to physical engineering risks (such as wobbly arms and the need for a finalized digital resistance system).

The Investment Catalyst: This is exactly where an investor sees opportunity. They want to see a clear engineering roadmap demonstrating that their capital will be used to correct these mechanical constraints, unlock the electronic resistance system, and elevate the machine to a fully certified, clinic-grade product.